Company profile

The Namibian Oncology Centre (Pty) Ltd

The Namibian Oncology Centre (Pty) Ltd (NOC) is a Namibia-based private specialist cancer care provider incorporated in 2015 and headquartered in Windhoek, Namibia. The company operates three active facilities, two in Windhoek (Eros and Khomasdal) and one in Swakopmund — with a fourth facility under construction in Ongwediva, anticipated to open in mid-2026. NOC delivers radiation therapy, medical oncology, haematology oncology, stem cell transplantation, prostate brachytherapy, paediatric oncology, palliative care, and a full suite of patient support services. The centre operates Namibia's only two linear accelerators and maintains a 16-bed oncology ward inclusive of a specialist isolation unit. Founded by Namibian clinicians, healthcare professionals, and private investors, NOC was acquired in 2026 by Salt Oncology Holdings — a special purpose vehicle comprising Salt Capital, FISEA (managed by Proparco/AFD), and Jan Bosch Investment Limited, and continues to operate as an independent provider under existing management.

Sector
Healthcare / Specialty Healthcare Providers, Primary Care Providers
Markets
Namibia
Founded
2015
Ownership
Private
Stage
Large Enterprise
Employees
51-200
Business model
B2C Transactional

Products and services

Radiation Therapy (Linear Accelerator-Based), Chemotherapy Services, Oncology Pharmacy, Haematology Oncology, Paediatric Oncology, Prostate Brachytherapy & Stem Cell Transplantation

Source: Partner Researchers.